Investigator site
Lille
0 studies enrolling now · 2 studies all time
What they study most
Acquired Thrombotic Thrombocytopenic Purpura
Studies at this site
Phase III Trial With Caplacizumab in Patients With Acquired Thrombotic Thrombocytopenic Purpura
— Completed
Follow-up Study for Patients Who Completed Study ALX0681-C301 (Post-HERCULES)
— Completed